Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Current Dermatology Reports
Published in: Current Dermatology Reports 3/2016

01-09-2016 | Laser Therapy (J Jagdeo, Section Editor)

Laser Revision and Rehabilitation of Mohs Micrographic Surgical Scars

Authors: Michael C. Cameron, Reyna Swift, Ashley Wysong, Anthony M. Rossi

Published in: Current Dermatology Reports | Issue 3/2016

Login to get access

Abstract

The use of Mohs micrographic surgery has become standard of care to treat a multitude of skin cancers to ensure tissue preservation. However, with any skin surgery, a cutaneous scar is the byproduct, and thus, laser scar revision has become mainstay of treatment. By utilizing varying laser wavelengths, different components that make up a particular scar can be targeted. Lasers are being used to improve scar texture, vascularity, pigmentation, and thickness, and it is important to understand the different uses and applications. Herein, we will review current practices for utilizing lasers or combination treatments to improve post Mohs surgery scars.
Literature
1.
Rogers HW, Weinstock MA, Harris AR, et al. Incidence estimate of nonmelanoma skin cancer in the United States, 2006. Arch Dermatol. 2010;146(3):283–7.PubMedCrossRef
2.
Connolly SM, Baker DR, Coldiron BM, et al. AAD/ACMS/ASDSA/ASMS 2012 appropriate use criteria for Mohs micrographic surgery: a report of the American Academy of Dermatology, American College of Mohs Surgery, American Society for Dermatologic Surgery Association, and the American Society for Mohs Surgery. J Am Acad Dermatol. 2012;67(4):531–50.PubMedCrossRef
3.
Kaeb S, Landthaler M, Hohenleutner U. Confocal laser scanning microscopy—evaluation of native tissue sections in micrographic surgery. Lasers Med Sci. 2009;24(5):819–23.PubMedCrossRef
4.
FE M. Chemosurgery: microscopically controlled surgery for skin cancer. Springfield, IL: Charles C Thomas; 1978.
5.
Mikhail GRM. Frederic Edward Mohs micrographic surgery. Philadelphia: W.B. Saunders; 1991.
6.
Rowe DE, Carroll RJ, Day Jr CL. Long-term recurrence rates in previously untreated (primary) basal cell carcinoma: implications for patient follow-up. J Dermatol Surg Oncol. 1989;15(3):315–28.PubMedCrossRef
7.
Rowe DE, Carroll RJ, Day Jr CL. Mohs surgery is the treatment of choice for recurrent (previously treated) basal cell carcinoma. J Dermatol Surg Oncol. 1989;15(4):424–31.PubMedCrossRef
8.
Hanke CW, Moy RL, Roenigk RK, et al. Current status of surgery in dermatology. J Am Acad Dermatol. 2013;69(6):972–1001.PubMedCrossRef
9.
Dixon AJ, Dixon MP, Dixon JB. Prospective study of long-term patient perceptions of their skin cancer surgery. J Am Acad Dermatol. 2007;57(3):445–53.PubMedCrossRef
10.•
Sobanko JF, Sarwer DB, Zvargulis Z, Miller CJ. Importance of physical appearance in patients with skin cancer. Dermatol Surg. 2015;41(2):183–8. This article denotes that scars, especially on the head and neck region, can negatively impact a patient’s psychosocial functioning.PubMedCrossRef
11.
Cassileth BR, Lusk EJ, Tenaglia AN. Patients’ perceptions of the cosmetic impact of melanoma resection. Plast Reconstr Surg. 1983;71(1):73–5.PubMedCrossRef
12.
Kasper DA, Cohen JL, Saxena A, Morganroth GS. Fillers for postsurgical depressed scars after skin cancer reconstruction. J Drugs Dermatol. 2008;7(5):486–7.PubMed
13.
Yarborough Jr JM. Ablation of facial scars by programmed dermabrasion. J Dermatol Surg Oncol. 1988;14(3):292–4.PubMedCrossRef
14.
15.
Bleasdale B, Finnegan S, Murray K, Kelly S, Percival SL. The use of silicone adhesives for scar reduction. Adv Wound Care. 2015;4(7):422–30.CrossRef
16.
Tierney E, Mahmoud BH, Srivastava D, Ozog D, Kouba DJ. Treatment of surgical scars with nonablative fractional laser versus pulsed dye laser: a randomized controlled trial. Dermatol Surg. 2009;35(8):1172–80.PubMedCrossRef
17.
Tanzi EL, Lupton JR, Alster TS. Lasers in dermatology: four decades of progress. J Am Acad Dermatol. 2003;49(1):1–31. quiz 31-34.PubMedCrossRef
18.
Goldman L, Blaney DJ, Kindel Jr DJ, Richfield D, Franke EK. Pathology of the effect of the laser beam on the skin. Nature. 1963;197:912–4.PubMedCrossRef
19.
Castro DJ, Abergel RP, Meeker C, Dwyer RM, Lesavoy MA, Uitto J. Effects of the Nd:YAG laser on DNA synthesis and collagen production in human skin fibroblast cultures. Ann Plast Surg. 1983;11(3):214–22.PubMedCrossRef
20.
Alster TS. Improvement of erythematous and hypertrophic scars by the 585-nm flashlamp-pumped pulsed dye laser. Ann Plast Surg. 1994;32(2):186–90.PubMedCrossRef
21.
Alster TS, Williams CM. Treatment of keloid sternotomy scars with 585 nm flashlamp-pumped pulsed-dye laser. Lancet. 1995;345(8959):1198–200.PubMedCrossRef
22.
Kim DH, Ryu HJ, Choi JE, Ahn HH, Kye YC, Seo SH. A comparison of the scar prevention effect between carbon dioxide fractional laser and pulsed dye laser in surgical scars. Dermatol Surg. 2014;40(9):973–8.PubMedCrossRef
23.
Alster TS, Lupton JR. Are all infrared lasers equally effective in skin rejuvenation. Semin Cutan Med Surg. 2002;21(4):274–9.PubMedCrossRef
24.
Kim SG, Kim EY, Kim YJ, Lee SI. The efficacy and safety of ablative fractional resurfacing using a 2,940-Nm Er:YAG laser for traumatic scars in the early posttraumatic period. Arch Plast Surg. 2012;39(3):232–7.PubMedPubMedCentralCrossRef
25.
Manuskiatti W, Triwongwaranat D, Varothai S, Eimpunth S, Wanitphakdeedecha R. Efficacy and safety of a carbon-dioxide ablative fractional resurfacing device for treatment of atrophic acne scars in Asians. J Am Acad Dermatol. 2010;63(2):274–83.PubMedCrossRef
26.
Waibel JS, Wulkan AJ, Shumaker PR. Treatment of hypertrophic scars using laser and laser assisted corticosteroid delivery. Lasers Surg Med. 2013;45(3):135–40.PubMedCrossRef
27.
Sclafani AP, Sclafani JA, Sclafani AM. Successes, revisions, and postoperative complications in 446 Mohs defect repairs. Facial Plast Surg. 2012;28(3):358–65.PubMedCrossRef
28.
Alster TS, Williams CM. Treatment of keloid sternostomy scars with 585 nm flashlamp-pumped laser. Lancet. 1995;345:1198–2000.PubMedCrossRef
29.
Vazquez-Martinez O, Eichelmann K, Carcia-Melendez M, et al. Pulsed dye laser for early treatment of scars after dermatological surgery. J Drugs Dermatol. 2015;14(11):1209–12.PubMed
30.
Kono T, Ercocen AR, Nakazawa H, et al. The flashlamp-pumped pulsed dye laser (595 nm) treatment of hypertrophic scars in Asians. Ann Plast Surg. 2003;51(4):366–71.PubMedCrossRef
31.
McCraw JB, McCraw JA, Mcmellin A, et al. Prevention of unfavorable scars using early pulse dye laser treatments: a preliminary report. Ann Plast Surg. 1999;42:7–14.PubMedCrossRef
32.
Bellew SG, Weiss MA, Weiss RA. Comparison of intense pulsed light to 595-nm long-pulsed pulsed dye laser for treatment of hypertrophic surgical scars: a pilot study. J Drugs Dermatol. 2005;4(4):448–52.PubMed
33.
Nouri K, Jiminez GP, Harrison-Balestra C, et al. 585-nm pulsed dye laser in the treatment of surgical scars starting on the suture removal day. Dermatol Surg. 2003;29:65–73.PubMed
34.
Ortonne JP, Bissett DL. Latest insights into skin hyperpigmentation. J Investig Dermatol Symp Proc. 2008;13(1):10–4.PubMedCrossRef
35.
Bowes LE, Nouri K, Berman B, et al. Treatment of pigmented hypertrophic scars with the 585 nm pulsed dye laser and the 532 nm frequency-doubled Nd:YAG laser in the Q-switched and variable pulse modes: a comparative study. Dermatol Surg. 2002;28:714–9.PubMed
36.
Dierickx C, Goldman MP, Fitzpatrick RE. Laser treatment of erythematous/hypertrophic and pigmented scars in 26 patients. Plast Reconstr Surg. 1995;95(1):84–90.PubMedCrossRef
37.
Hultman CS, Friedstat JS, Edkins RE. Efficacy of intense pulsed light for the treatment of burn scar dyschromias: a pilot study to assess patient satisfaction, safety, and willingness to pay. Ann Plast Surg. 2015;74(supp 4):S204–8.PubMedCrossRef
38.
Kontoes PP, Marayiannis KV, Vlachos SP. The use of intense pulsed light in treatment of scars. Eur J Plast Surg. 2003;25:374–7.
39.••
Ha JM, Kim HS, Cho EB, et al. Comparison of the effectiveness of nonablative fractional laser versus pulsed-dye laser in thyroidectomy scar prevention. Ann Dermaoloty. 2014;26(5):615–20. This article compared the use of nonablative fractional lasers versus pulsed dye laser for the treatment of post surgical scars and showed no difference in improvement between the tow modlaities. Both types of lasers improved the scar appearance without significant difference between the two.CrossRef
40.
Shin JU, Gantsetseg D, Jung JY, et al. Comparison of non-ablative and ablative fractional laser treatments in a postoperative scar study. Lasers Surg Med. 2014;46:741–9.PubMedCrossRef
41.
Chadwick S, Heath R, Shah M. Abnormal pigmentation within cutaneous scars: a complication of wound healing. Indian J Plas Surg. 2012;45(2):403–11.CrossRef
42.
Velangi SS, Rees JL. Why are scars pale? An immunohistochemical study indicating preservation of melanocyte number and function in surgical scars. Acta Derm Venereol. 2001;81:326–8.PubMedCrossRef
43.
Alexiades-Armenakas MR, Bernstein LJ, Friedman PM, et al. The safety and efficacy of the 308 nm excimer laser for pigment correction of hypopigmented scars and striae. Arch Dermatol. 2004;140:955–60.PubMedCrossRef
44.
Glaich AS, Rahman Z, Goldberg LH, et al. Fractional resurfacing for the treatment of hypopigmented scars: a pilot study. Dermatol Surg. 2007;33(3):289–94.PubMed
45.
Anbar TS, El-Ammawi TS, Abdel-Rahman AT, et al. The effect of latanoprost on vitiligo: a preliminary comparative study. Int J Dermatol. 2015;54:587–93.PubMedCrossRef
46.•
Siadat AH, Rezaei R, Asilian A, et al. Repigmentation of hypopigmented scars using combination of fractionated carbon dioxide laser with topical latanoprost vs fractionated carbon dioxide laser alone. Indian J Dermatol. 2015;60(4):364–8. This article showed that the use of a fractionated carbon dioxide laser and topical lantaoprost can help to improve hypopigmented scars which can be quite difficult to treat.PubMedPubMedCentralCrossRef
47.
Massaki AB, Fabi SG, Fitzpatrick R. Repigmentation of hypopigmented scars using an erbium-doped 1550 nm fractionated laser and topical bimatoprost. Dermatol Surg. 2012;38:995–1001.PubMedCrossRef
48.
van Drooge AM, Vrijman C, van der Veen W, et al. A randomized controlled pilot study on ablative fractional CO2 laser for consecutive patients presenting wth various scar types. Dermatol Surg. 2015;41:371–7.PubMedCrossRef
49.
Midwood KS, Williams LV, Schqarzbauer JE. Tissue repair and the dynamics of the extracellular matrix. Int J Biochem Cell Biol. 2004;36(6):1031–7.PubMedCrossRef
50.
Lee SH, Zheng Z, Roh MR. Early postoperative treatment of surgical scars using a fractional carbon dioxide laser: a split-scar, evaluator blinded study. Dermatol Surg. 2013;39:1190–6.PubMedCrossRef
51.
Sobanko JF, Vachiramon V, Rattanaumpawan P, et al. Early postoperative single treatment lasing of Mohs micrographic surgery facial scars: a split-scar, evaluator-blinded study. Lasers Surg Med. 2015;47:1–5.PubMedCrossRef
52.
Stephan FE, Habre MB, Helou JF. Fractional CO2 laser treatment for a skin graft. J Cosmet Laser Ther. 2016;20:1–2.CrossRef
53.
Finney R, Torbeck R, Saedi N. Non-ablative fractional resurfacing in the treatment of scar contracture. Lasers Surg Med. 2015. Doi: 10.​1002/​lsm.​22400.
54.
Schulz KK, Walling HW. Fractional photothermolysis improves a depressed alar scar following Mohs micrographic surgery. J Drugs Dermatol. 2010;9(1):66–7.PubMed
55.
56.
57.
Leventhal D, Furr M, Reiter D. Treatment of keloids and hypertrophic scars: a meta-analysis and review of the literature. Arch Facial Plast Surg. 2006;8(6):362–8.PubMedCrossRef
58.
Alster TS, Tanzi EL. Hypertrophic scars and keloids: etiology and management. Am J Clin Dermatol. 2003;4(4):235–43.PubMedCrossRef
59.
Jin R, Huang X, Li H, et al. Laser therapy for prevention and treatment of pathologic excessive scars. Plast Reconstr Surg. 2013;132(6):1747–58.PubMedCrossRef
60.
Rossi A, Lu R, Frey MK, Kubota T, Smith LA, Perez M. The use of the 300 microsecond 1064 nm Nd:YAG laser in the treatment of keloids. J Drugs Dermatol. 2013;12(11):1256–62.PubMed
61.
Cavalie M, Sillard L, Montaudie H, Bahadoran P, Lacour JP, Passeron T. Treatment of keloids with laser-assisted topical steroid delivery: a retrospective study of 23 cases. Dermatol Ther. 2015;28(2):74–8.PubMedCrossRef
Metadata
Title
Laser Revision and Rehabilitation of Mohs Micrographic Surgical Scars
Authors
Michael C. Cameron
Reyna Swift
Ashley Wysong
Anthony M. Rossi
Publication date
01-09-2016
Publisher
Springer US
Published in
Current Dermatology Reports / Issue 3/2016
Electronic ISSN: 2162-4933
DOI
https://doi.org/10.1007/s13671-016-0144-7

Other articles of this Issue 3/2016

Current Dermatology Reports 3/2016 Go to the issue

Laser Therapy (J Jagdeo, Section Editor)

The Evolution and Current Best Treatments for Traumatic, Surgical, and Burn Scars

Medical Surgery (M Alam, Section Editor)

Staged Excision: Tips and Pitfalls

Medical Surgery (M Alam, Section Editor)

Reflectance Confocal Microscopy for Skin Cancer Margins: How it Works

Medical Surgery (M Alam, Section Editor)

Surgical Treatment of Cutaneous Extramammary Paget’s Disease

Laser Therapy (J Jagdeo, Section Editor)

Tattoos and Beyond: the Clinical Evolution of Picosecond Laser Technology

Laser Therapy (J Jagdeo, Section Editor)

How Wounding via Lasers Has Potential Photocarcinogenic Preventative Effects via Dermal Remodeling